Fent Genevieve M, Casteel Stan W, Kim Dae Young, Kannan Raghuraman, Katti Kavita, Chanda Nripen, Katti Kattesh
Department of Veterinary Pathobiology, University of Missouri, Columbia, Missouri, USA.
Nanomedicine. 2009 Jun;5(2):128-35. doi: 10.1016/j.nano.2009.01.007.
This article describes several experiments performed to test our hypothesis that the agent used to coat/stabilize gold nanoparticles (AuNPs) will act to direct the AuNPs to specific tissues within the body and that changing the coating will change the target organ. Samples were also collected for pathological examination. Gum arabic- (GA) and maltose- (MALT) stabilized AuNPs were administered intravenously to juvenile swine, and blood, tissue, and urine samples were collected for gold analysis. Our results indicate that differences do exist between the two NP constructs tested, with 50% or greater of the total gold dose being found in the liver or lung for the GA- and MALT-stabilized AuNPs, respectively. These findings indicate that the functional unit used to coat/stabilize the AuNPs has an important role in determining the tissue distribution profile for individual AuNP constructs.
本文描述了为检验我们的假设而进行的若干实验。我们的假设是,用于包覆/稳定金纳米颗粒(AuNPs)的试剂将促使AuNPs靶向体内特定组织,并且改变包覆层会改变靶器官。还收集了样本用于病理检查。将阿拉伯胶(GA)和麦芽糖(MALT)稳定的AuNPs静脉注射给幼猪,并收集血液、组织和尿液样本进行金分析。我们的结果表明,所测试的两种纳米颗粒构建体之间确实存在差异,GA稳定的AuNPs和MALT稳定的AuNPs分别有50%或更多的总金剂量存在于肝脏或肺中。这些发现表明,用于包覆/稳定AuNPs的功能单元在确定单个AuNP构建体的组织分布情况方面起着重要作用。